Abdurrahman Özgür
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdurrahman Özgür has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Alper Şişmanoğlu
Resident in Obstetrics and Gynecology, Marmara University School of Medicine, Istanbul, Turkey
1 shared publication- Bahadır Şahin
Department of Urology, School of Medicine, Marmara University, Istanbul, Turkey
1 shared publication C. Yazıcı
Marmara University School of Medicine
1 shared publicationCenk Yazici
Department of Urology, Marmara University School of Medicine, Marmara University Hospital, Istanbul, Turkey
1 shared publication- Deniz Filinte
Marmara Univ, Fac Med, Dept Pathol, Istanbul, Turkey
1 shared publication Devrim Tezen
Resident in Obstetrics and Gynecology, Marmara University School of Medicine, Istanbul, Turkey
1 shared publication
Latest Publications
- 13 December 2022
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 21 (4) , 140-141
Bladder Explosion, a Serious Complication Occurred During Transurethral Resection of Prostate
- 13 December 2022
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 21 (4) , 140-141
Bladder Explosion, a Serious Complication Occurred During Transurethral Resection of Prostate
- 1 March 2022
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 21 (1) , 10-13
Risk Factors of Patients with Prostate Cancer Upgrading for International Society of Urological Pathology Grade Group I After Radical Prostatectomy
- 1 March 2022
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 21 (1) , 10-13
Risk Factors of Patients with Prostate Cancer Upgrading for International Society of Urological Pathology Grade Group I After Radical Prostatectomy
- 1 September 2021
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 8 (3) , 198-201
Evaluation of Erectile Function in Patients Undergoing Hemodialysis
- 1 September 2021
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 8 (3) , 198-201
Evaluation of Erectile Function in Patients Undergoing Hemodialysis
- 1 March 2005
- Published by Springer Nature in International Urology and Nephrology
- Vol. 37 (1) , 9-11
Extracorporeal Shock Wave Lithotripsy of Renal Pelvis Stones with PCK Stonelith Lithotripter
Shock wave lithotripsy (SWL) has made a revolution in the treatment of urolithiasis. It is a safe procedure with a lower morbidity than open surgery or percutaneous nefrolithotomy (PCN) [Brannen GE, Bush WH, Correa RJ et al., J Urol 1985; 133: 6 and Lingeman JE, Newman D, Mertz JHO et al., J UROL 1986; 135: 1134]. In this article, we analyze our results of SWL with PCK Stonelith-V5 Lithotripter for the renal pelvis localized stones. About 97 patients with radiopaque stone localized in the renal pelvis were treated with PCK lithotripter from January 2001 to March 2003. The study group was divided into two groups according to their stone size. The stone size was ≤ 10 mm in the first group and 11–20 mm in the second group. 56(57) patients were male and 41 (43) were female. Age range was 7–68 (mean 44) years. The overall success rates of SWL for the treatment of renal pelvic stones in our study group was 35 and 62.2 for stones 10 mm or less and 11–20 mm, respectively. Since the focal zone is 7.7 × 30 mm, the stones can easily get out of the focal zone area with respiration and as a result, the success rate is decreased. So, general anesthesia can be preferred for the treatment of stones ≤10 mm with the PCK Stonelith Lithotripter.
- 1 March 2005
- Published by Springer Nature in International Urology and Nephrology
- Vol. 37 (1) , 9-11
Extracorporeal Shock Wave Lithotripsy of Renal Pelvis Stones with PCK Stonelith Lithotripter
Shock wave lithotripsy (SWL) has made a revolution in the treatment of urolithiasis. It is a safe procedure with a lower morbidity than open surgery or percutaneous nefrolithotomy (PCN) [Brannen GE, Bush WH, Correa RJ et al., J Urol 1985; 133: 6 and Lingeman JE, Newman D, Mertz JHO et al., J UROL 1986; 135: 1134]. In this article, we analyze our results of SWL with PCK Stonelith-V5 Lithotripter for the renal pelvis localized stones. About 97 patients with radiopaque stone localized in the renal pelvis were treated with PCK lithotripter from January 2001 to March 2003. The study group was divided into two groups according to their stone size. The stone size was ≤ 10 mm in the first group and 11–20 mm in the second group. 56(57) patients were male and 41 (43) were female. Age range was 7–68 (mean 44) years. The overall success rates of SWL for the treatment of renal pelvic stones in our study group was 35 and 62.2 for stones 10 mm or less and 11–20 mm, respectively. Since the focal zone is 7.7 × 30 mm, the stones can easily get out of the focal zone area with respiration and as a result, the success rate is decreased. So, general anesthesia can be preferred for the treatment of stones ≤10 mm with the PCK Stonelith Lithotripter.
- 1 March 2005
- Published by Springer Nature in International Urology and Nephrology
- Vol. 37 (1) , 31-34
Treatment of Ureteral Stones Using Holmium:YAG laser
Introduction: There has been a steady increase in the number of ureteroscopic laser lithotripsy. In addition to its soft tissue applications Holmium:YAG laser has also been found an excellent intracorporeal lithotripter for all kinds of stones. We here present the results of patients treated with Holmium: YAG laser lithotripsy in our clinic. Methods: Between June 1997 and December 2002, 205 patients with a diagnosis of ureteric calculi were treated with ureteroscopy using Holmium:YAG laser as an intracorporeal lithotriptor. The stones were localized in the distal ureter in 158 patients (77), middle and proximal ureter in 47 patients (23). Stones ranged in size from 5 × 5 mm to 20 × 10 mm and the operation time was about 35 minutes (ranged 25–65 minutes). Follow-up evaluations have done at first and third months. Results: The ureteral stone could not be reached in 10 patients (4.8). Stone fragmentation or removal was accomplished in all other patients. Four patients (1.9) had proximal migration of the fragments and later treated with extra corporeal shock wave lithotripsy, and three patients (1.5) had ureteral perforation. They were managed by double J stent placement. Two of the patients had ureteral obstruction on the third month of procedure. One of the patients was treated with open surgery. For the other one, ureteroscopic balloon dilatation was performed and catheterized by double J stent and there wasn’t any complication after the removal of stent. Conclusions: Ureteroscopic Holmium:YAG laser lithotripsy is a safe, technically feasible and efficacious treatment for ureteral stones.
- 1 March 2005
- Published by Springer Nature in International Urology and Nephrology
- Vol. 37 (1) , 31-34
Treatment of Ureteral Stones Using Holmium:YAG laser
Introduction: There has been a steady increase in the number of ureteroscopic laser lithotripsy. In addition to its soft tissue applications Holmium:YAG laser has also been found an excellent intracorporeal lithotripter for all kinds of stones. We here present the results of patients treated with Holmium: YAG laser lithotripsy in our clinic. Methods: Between June 1997 and December 2002, 205 patients with a diagnosis of ureteric calculi were treated with ureteroscopy using Holmium:YAG laser as an intracorporeal lithotriptor. The stones were localized in the distal ureter in 158 patients (77), middle and proximal ureter in 47 patients (23). Stones ranged in size from 5 × 5 mm to 20 × 10 mm and the operation time was about 35 minutes (ranged 25–65 minutes). Follow-up evaluations have done at first and third months. Results: The ureteral stone could not be reached in 10 patients (4.8). Stone fragmentation or removal was accomplished in all other patients. Four patients (1.9) had proximal migration of the fragments and later treated with extra corporeal shock wave lithotripsy, and three patients (1.5) had ureteral perforation. They were managed by double J stent placement. Two of the patients had ureteral obstruction on the third month of procedure. One of the patients was treated with open surgery. For the other one, ureteroscopic balloon dilatation was performed and catheterized by double J stent and there wasn’t any complication after the removal of stent. Conclusions: Ureteroscopic Holmium:YAG laser lithotripsy is a safe, technically feasible and efficacious treatment for ureteral stones.
- 1 September 2004
- Published by Springer Nature in International Urology and Nephrology
- Vol. 36 (3) , 345-348
Intravesical stone formation on intrauterine contraceptive device
Since more than 30 years, intrauterine contraceptive devices (IUCD) have been used for a contraceptive opportunity. Although they are termed to be a safe and effective method for contraception, they also have some type of complications and uterine perforation, septic abortion, pelvic abscess are the serious complications of these devices. The incidence of uterine perforation is very low, but in the literature nearly 100 cases were reported about the extra uterine localization of IUCD. Migration may occur to the adjacent organs. We here in describe a case of a 31 year-old woman who had an IUCD with stone formation in the bladder. In the literature all of the cases were reported as IUCD migration, but although it seems technically impossible, IUCD placement into the bladder should also be considered in misplaced IUCDs.
- 1 September 2004
- Published by Springer Nature in International Urology and Nephrology
- Vol. 36 (3) , 345-348
Intravesical stone formation on intrauterine contraceptive device
Since more than 30 years, intrauterine contraceptive devices (IUCD) have been used for a contraceptive opportunity. Although they are termed to be a safe and effective method for contraception, they also have some type of complications and uterine perforation, septic abortion, pelvic abscess are the serious complications of these devices. The incidence of uterine perforation is very low, but in the literature nearly 100 cases were reported about the extra uterine localization of IUCD. Migration may occur to the adjacent organs. We here in describe a case of a 31 year-old woman who had an IUCD with stone formation in the bladder. In the literature all of the cases were reported as IUCD migration, but although it seems technically impossible, IUCD placement into the bladder should also be considered in misplaced IUCDs.
- 1 November 2003
- Vol. 56 (9) , 1072-4
An unusual tumor of the spermatic cord: myositis ossificans.
Tumors of the spermatic cord and epididymis are rare, and their exact incidence is difficult to determine. Ninety percent of extra testicular tumors within the scrotum are found in the spermatic cord, where 30% is malignant (1). In this case report we present an unusual spermatic cord tumor, i.e. myositis ossificans (MO). To the best of our knowledge, MO of the spermatic cord has not been reported before in the literature. MO should be considered in the differential diagnosis of the spermatic cord tumors.
- 1 November 2003
- Vol. 56 (9) , 1072-4
An unusual tumor of the spermatic cord: myositis ossificans.
Tumors of the spermatic cord and epididymis are rare, and their exact incidence is difficult to determine. Ninety percent of extra testicular tumors within the scrotum are found in the spermatic cord, where 30% is malignant (1). In this case report we present an unusual spermatic cord tumor, i.e. myositis ossificans (MO). To the best of our knowledge, MO of the spermatic cord has not been reported before in the literature. MO should be considered in the differential diagnosis of the spermatic cord tumors.
- 1 September 2003
- Vol. 56 (7) , 859-61
Cervical lymph node enlargement on the right side as the initial manifestation of metastatic prostate cancer.
Cervical lymph node enlargement (LAP) due to metastatic spread is an uncommon manifestation of prostatic adenocarcinoma. In case of non-regional lymphatic spread, left supraclavicular region was found to be the most common site (1,2,3) whereas right sided metastatic lymph node involvement has been extremely uncommon. We here in describe a case of a 75 year-old man who had an enlarged cervical lymph node for a year which subsequently proved to be involved by metastatic adenocarcinoma of the prostate. Although, prostate cancer rarely metastasize to the cervical lymph node chain it should always be considered in the differential diagnosis of metastatic lymph node enlargement in the cervical area of elderly men.
- 1 September 2003
- Vol. 56 (7) , 859-61
Cervical lymph node enlargement on the right side as the initial manifestation of metastatic prostate cancer.
Cervical lymph node enlargement (LAP) due to metastatic spread is an uncommon manifestation of prostatic adenocarcinoma. In case of non-regional lymphatic spread, left supraclavicular region was found to be the most common site (1,2,3) whereas right sided metastatic lymph node involvement has been extremely uncommon. We here in describe a case of a 75 year-old man who had an enlarged cervical lymph node for a year which subsequently proved to be involved by metastatic adenocarcinoma of the prostate. Although, prostate cancer rarely metastasize to the cervical lymph node chain it should always be considered in the differential diagnosis of metastatic lymph node enlargement in the cervical area of elderly men.